Evidence map›Paper›PMID 32311899›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Clinical analysis of 10 patients of acute promyelocytic leukemia with a variant RARα translocation].

R H Mi, L Chen, J Liu, T Liu, K Wang, L H Dong, X Li, Y Z He, Z B Liu, X J Guo and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

R H MiHenan Cancer Hospital/the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
L ChenHenan Cancer Hospital/the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
J LiuHenan Cancer Hospital/the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
T LiuZhoukou Central Hospital, Zhoukou 466000,China.
K WangZhoukou Central Hospital, Zhoukou 466000,China.
L H DongHenan Cancer Hospital/the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
X LiHenan University First Affiliated Hospital, Kaifeng 475004, China.
Y Z HePuyang City Oilfield General Hospital, Puyang 457001, China.
Z B LiuPuyang City Oilfield General Hospital, Puyang 457001, China.
X J GuoPuyang City Oilfield General Hospital, Puyang 457001, China.
S L GuoLuoyang Central Hospital, Luoyang 471099, China.
H M ZhaoHenan University Huaihe Hospital, Kaifeng 475399, China.
J H TangPeople's Liberation Army in the 988 Hospital (Kaifeng District), Kaifeng 475002, China.
X M MaPingdingshan First People's Hospital,Pingdingshan 467021, China.
Y F LiHenan Cancer Hospital/the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
X D WeiHenan Cancer Hospital/the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Promyelocytic, AcuteHumansOncogene Proteins, FusionRetinoic Acid Receptor alphaTranslocation, GeneticTretinoinOncogene Proteins, FusionRetinoic Acid Receptor alphaTretinoin

Identifiers

PMID32311899
PMCPMC7357931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.